To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene NUDT22andDNAJC4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
565 representative clones for gene NUDT22andDNAJC4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_032344.2   .a 1 to 1117 1 to 1117 Q267R L270P RefSeq, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 1117/1117
(100 %)
2 diff
(99.9 %id)
TI_57233088   .a 8 to 847 15 to 870       856/875
(97 %)
36 diff
(95.9 %id)
BI906651 leukocyte .a 23 to 847 1 to 842   tiling clone,   842/847
(99 %)
31 diff
(96.4 %id)
BC006129 Uterus, endometrium adenocarcinoma .a 25 to 1117 1 to 1093 Q267R L270P tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 1093/1093
(100 %)
2 diff
(99.9 %id)
BI909152 leukocyte .a 25 to 754 1 to 734       734/734
(100 %)
6 diff
(99.2 %id)
BI836187 pooled pancreas and spleen .a 25 to 763 1 to 745       745/745
(100 %)
11 diff
(98.6 %id)
TI_57236717   .a 25 to 754 32 to 765       734/765
(95 %)
7 diff
(99.1 %id)
TI_57164894   .a 25 to 763 34 to 778       745/778
(95 %)
13 diff
(98.4 %id)
BM922650 leukocyte .a 28 to 860 23 to 855       833/1031
(80 %)
18 diff
(98.3 %id)
CN261714 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 34 to 686 1 to 653       653/653
(100 %)
2 diff
(99.7 %id)
CR614915 Placenta Cot 25-normalized .a 34 to 1088 1 to 1055   tiling clone,   1055/1055
(100 %)
0 diff
(100 %id)
BX357359 Placenta Cot 25-normalized .a 34 to 790 1 to 757   fully sequenced,   757/757
(100 %)
3 diff
(99.7 %id)
BM925221 pooled lung and spleen .a 37 to 856 1 to 822       822/1055
(77 %)
24 diff
(97.8 %id)
BI761895 pooled colon, kidney, stomach .a 41 to 821 1 to 780       780/781
(99 %)
9 diff
(98.9 %id)
BI766420 pooled lung and spleen .a 41 to 762 1 to 723       723/723
(100 %)
6 diff
(99.2 %id)
CF126415 Chondrosarcoma Lung Metastasis cell lines, lung .a 41 to 817 1 to 775       775/775
(100 %)
6 diff
(99.3 %id)
TI_57150951   .a 41 to 821 31 to 810       780/811
(96 %)
11 diff
(98.7 %id)
TI_57177733   .a 41 to 762 35 to 757       723/757
(95 %)
12 diff
(98.5 %id)
TI_154189402   .a 41 to 860 51 to 862       812/986
(82 %)
16 diff
(98.4 %id)
CR602818 Placenta Cot 25-normalized .a 46 to 1059 1 to 1014       1014/1014
(100 %)
0 diff
(100 %id)
BX398117 Placenta Cot 25-normalized .a 46 to 790 1 to 745   fully sequenced,   745/745
(100 %)
8 diff
(99.0 %id)
BG289871 bladder, transitional cell papilloma, cell line .a 47 to 762 1 to 715       715/732
(97 %)
7 diff
(99.1 %id)
BQ225591 epithelioid carcinoma, Pancreas .a 52 to 858 1 to 808       808/869
(92 %)
5 diff
(99.5 %id)
BI905995 leukocyte .a 56 to 863 1 to 807       805/851
(94 %)
31 diff
(96.4 %id)
TI_57231404   .a 56 to 863 35 to 841       805/885
(90 %)
36 diff
(96.0 %id)
BU526805 epidermoid carcinoma, cell line, lung .a 59 to 909 1 to 856       856/911
(93 %)
9 diff
(99.1 %id)
TI_57200102   .a 66 to 926 65 to 925       861/925
(93 %)
11 diff
(98.9 %id)
BI911550 leukocyte .a 68 to 894 30 to 851       822/851
(96 %)
12 diff
(98.6 %id)
BI911490 leukocyte .a 68 to 733 31 to 700       670/700
(95 %)
10 diff
(98.6 %id)
TI_57232821   .a 68 to 733 31 to 700       670/700
(95 %)
10 diff
(98.6 %id)
TI_57232898   .a 68 to 894 30 to 851       822/851
(96 %)
12 diff
(98.6 %id)
TI_57162477   .a 68 to 763 33 to 727       695/728
(95 %)
8 diff
(99.0 %id)
BI832811 pooled pancreas and spleen .a 69 to 763 1 to 694       694/695
(99 %)
2 diff
(99.8 %id)
CF127897 Chondrosarcoma Lung Metastasis cell lines, lung .a 69 to 855 1 to 783       783/785
(99 %)
5 diff
(99.4 %id)
TI_154193588   .a 69 to 915 51 to 884       836/1006
(83 %)
12 diff
(98.9 %id)
BF791671 adrenal cortex carcinoma, cell line, adrenal gland .a 70 to 843 1 to 782       782/956
(81 %)
17 diff
(98.3 %id)
CA488791   .a 71 to 943 1 to 885       885/890
(99 %)
27 diff
(97.0 %id)
BI818814 pooled brain, lung, testis .a 74 to 926 1 to 853       853/853
(100 %)
5 diff
(99.5 %id)
BM555596 amelanotic melanoma, cell line, skin .a 83 to 860 1 to 780       780/994
(78 %)
4 diff
(99.6 %id)
BM915619 amelanotic melanoma, cell line, skin .a 84 to 951 1 to 884       884/1052
(84 %)
28 diff
(97.4 %id)
BQ688327 ductal carcinoma, cell line, Pancreas .a 88 to 1052 1 to 963       963/963
(100 %)
12 diff
(98.8 %id)
BQ691981 ductal carcinoma, cell line, Pancreas .a 88 to 951 1 to 864       864/951
(90 %)
10 diff
(99.0 %id)
BM551080 duodenal adenocarcinoma, cell line, small intestine .a 118 to 950 1 to 837       837/1112
(75 %)
26 diff
(97.7 %id)
CN261715 embryonic stem cells, cell lines H1, H7, andH9 .a 127 to 693 1 to 567       567/567
(100 %)
0 diff
(100 %id)
BI837310 pooled pancreas and spleen .a 145 to 781 1 to 644       644/644
(100 %)
9 diff
(98.7 %id)
BX357358 Placenta Cot 25-normalized .a 729 to 1088 360 to 1   fully sequenced,   360/360
(100 %)
5 diff
(98.7 %id)
BX398116 Placenta Cot 25-normalized .a 729 to 1059 331 to 1   fully sequenced,   331/331
(100 %)
2 diff
(99.4 %id)
BU528228 epidermoid carcinoma, cell line, lung .b 1 to 869 5 to 883   tiling clone,   883/883
(100 %)
15 diff
(98.4 %id)
BM671819 eye, optic nerve .b 851 to 1370 538 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 520/529
(98 %)
2 diff
(99.7 %id)
BG325759 Kidney, renal cell adenocarcinoma .c 1 to 747 1 to 744   tiling clone,   744/744
(100 %)
7 diff
(99.1 %id)
BG705568 brain, hypothalamus .c 314 to 1015 1 to 702       702/705
(99 %)
8 diff
(98.9 %id)
TI_59392843   .c 325 to 1195 45 to 916       872/873
(99 %)
24 diff
(97.3 %id)
BM014784 breast, mammary adenocarcinoma, cell line .c 327 to 1195 1 to 870       870/871
(99 %)
24 diff
(97.3 %id)
NM_001128612.1   .c 327 to 1313 1 to 987 Q260R L263P RefSeq, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 987/987
(100 %)
2 diff
(99.8 %id)
DN997362 breast cancer, Mammary gland (cancer tissue) .c 342 to 937 9 to 604       596/604
(98 %)
0 diff
(100 %id)
TI_57168411   .c 349 to 977 42 to 677       636/677
(93 %)
7 diff
(99.0 %id)
BI831247 brain, medulla .c 350 to 1054 1 to 707       707/756
(93 %)
24 diff
(96.9 %id)
BI457433 epithelioid carcinoma cell line, Pancreas .c 350 to 1146 6 to 800       793/907
(87 %)
17 diff
(98.2 %id)
TI_45133524   .c 350 to 1146 63 to 857       793/906
(87 %)
17 diff
(98.2 %id)
CR619666 placenta .c 358 to 1273 1 to 916   tiling clone,   916/916
(100 %)
0 diff
(100 %id)
BI911594 leukocyte .c 358 to 1168 33 to 843       811/843
(96 %)
19 diff
(97.8 %id)
BQ946682 epidermoid carcinoma, cell line, lung .c 358 to 1056 7 to 717       711/1061
(67 %)
25 diff
(97.7 %id)
TI_57232963   .c 358 to 1168 33 to 843       811/843
(96 %)
19 diff
(97.8 %id)
TI_57176925   .c 358 to 1054 77 to 775       699/824
(84 %)
23 diff
(97.3 %id)
AL540323 placenta .c 359 to 1084 1 to 726   fully sequenced,   726/726
(100 %)
6 diff
(99.2 %id)
CN261716 embryonic stem cells, cell lines H1, H7, andH9 .c 376 to 1013 1 to 639       639/639
(100 %)
1 diff
(99.9 %id)
TI_1948103705   .c 376 to 920 133 to 675   fully sequenced,   543/675
(80 %)
8 diff
(98.9 %id)
TI_1948103845   .c 376 to 903 128 to 668       539/1498
(35 %)
15 diff
(99.0 %id)
TI_1948103985   .c 376 to 857 129 to 610       482/1492
(32 %)
1 diff
(100.0 %id)
CV026956 mixed .c 377 to 925 1 to 549       549/549
(100 %)
3 diff
(99.5 %id)
CR978606 T-Lymphocytes .c 385 to 870 1 to 486       486/486
(100 %)
0 diff
(100 %id)
CR980579 T-Lymphocytes .c 385 to 931 1 to 547       547/547
(100 %)
0 diff
(100 %id)
CR979107 T-Lymphocytes .c 385 to 935 1 to 551       551/551
(100 %)
0 diff
(100 %id)
CT003466 T-Lymphocytes .c 385 to 968 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BG178228 adenocarcinoma, cell line, Prostate .c 395 to 1134 1 to 746       746/884
(84 %)
18 diff
(98.0 %id)
BM558796 amelanotic melanoma, cell line, skin .c 397 to 1313 1 to 926   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 926/926
(100 %)
17 diff
(98.2 %id)
T87974 liver and spleen .c 399 to 688 1 to 287       287/289
(99 %)
7 diff
(97.6 %id)
BF034379 adenocarcinoma, ovary .c 404 to 1079 1 to 675       675/677
(99 %)
8 diff
(98.9 %id)
TI_154055469   .c 432 to 1313 953 to 88   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 866/1004
(86 %)
30 diff
(97.1 %id)
BX335177 Placenta Cot 25-normalized .c 485 to 1155 224 to 894       671/814
(82 %)
10 diff
(98.8 %id)
TI_154104611   .c 504 to 1313 882 to 81   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 802/985
(81 %)
13 diff
(98.7 %id)
H53939 liver and spleen .c 521 to 791 1 to 271       271/274
(98 %)
3 diff
(99.0 %id)
AA479457 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 522 to 822 1 to 300   fully sequenced,   300/300
(100 %)
1 diff
(99.7 %id)
BM545605 ovary (pool of 3) .c 562 to 1318 1 to 763       763/1009
(75 %)
12 diff
(98.9 %id)
CN261717 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 580 to 1213 20 to 652       633/652
(97 %)
9 diff
(98.7 %id)
TI_149277475   .c 608 to 1315 798 to 92   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 707/707
(100 %)
4 diff
(99.5 %id)
BU677627 lung .c 630 to 1315 702 to 17   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 686/686
(100 %)
2 diff
(99.8 %id)
BG280974 melanotic melanoma, skin .c 636 to 1313 1 to 673   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 673/673
(100 %)
10 diff
(98.6 %id)
BG281912 melanotic melanoma, skin .c 636 to 1314 1 to 676       676/693
(97 %)
8 diff
(98.9 %id)
CA418672 Chondrosarcoma Grade II, Left Pelvis .c 636 to 1313 695 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 677/677
(100 %)
3 diff
(99.6 %id)
CA431423 cell lines, Enchondroma .c 638 to 1313 694 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 676/676
(100 %)
2 diff
(99.8 %id)
BQ222630 epithelioid carcinoma, Pancreas .c 655 to 1313 1 to 658   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 658/658
(100 %)
3 diff
(99.6 %id)
BE384422 melanotic melanoma, skin .c 656 to 1314 1 to 656       656/664
(98 %)
7 diff
(99.0 %id)
BQ929254 epidermoid carcinoma, cell line, lung .c 657 to 1236 1 to 590       590/1085
(54 %)
16 diff
(98.6 %id)
BU627527 Bone, Enchondroma cell line .c 661 to 1313 670 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 652/652
(100 %)
3 diff
(99.6 %id)
BU627419 Bone, Enchondroma cell line .c 661 to 1313 671 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 653/653
(100 %)
3 diff
(99.6 %id)
BU625296 cell lines, Enchondroma .c 661 to 1313 670 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 652/652
(100 %)
3 diff
(99.6 %id)
BU622367 cell lines, Chondrosarcoma .c 661 to 1313 670 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 652/652
(100 %)
3 diff
(99.6 %id)
BQ004418 Chondrosarcoma, Left Pelvis .c 662 to 1313 669 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 651/651
(100 %)
3 diff
(99.6 %id)
TI_149314793   .c 697 to 1313 673 to 70   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 604/889
(67 %)
24 diff
(97.4 %id)
AA465296 germinal center B cell .c 700 to 1173 1 to 477       477/477
(100 %)
10 diff
(98.0 %id)
AI126522 uterus .c 731 to 1187 457 to 1       457/457
(100 %)
2 diff
(99.6 %id)
AI139537 uterus .c 731 to 1179 449 to 1       449/449
(100 %)
2 diff
(99.6 %id)
BE889886 leiomyosarcoma, uterus .c 759 to 1308 1 to 549       549/549
(100 %)
5 diff
(99.1 %id)
TI_157609793   .c 765 to 1313 651 to 103   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 549/549
(100 %)
10 diff
(98.2 %id)
AW026541 brain, glioblastoma (pooled) .c 791 to 1313 523 to 1       523/523
(100 %)
2 diff
(99.7 %id)
AA479349 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 792 to 1142 350 to 1   fully sequenced,   350/350
(100 %)
1 diff
(99.8 %id)
EC551601 Prostate .c 829 to 928 1 to 101       101/101
(100 %)
2 diff
(98.1 %id)
W81547 heart .c 839 to 986 1 to 145   fully sequenced,   147/147
(100 %)
5 diff
(96.6 %id)
AA527473 colon .c 843 to 1314 470 to 1       470/473
(99 %)
5 diff
(99.0 %id)
AI222786 adenocarcinoma, colon .c 844 to 1314 475 to 5       471/475
(99 %)
0 diff
(100 %id)
AA345903 gall bladder .c 845 to 1090 1 to 247       247/247
(100 %)
1 diff
(99.6 %id)
H53940 liver and spleen .c 847 to 1310 475 to 7       469/485
(96 %)
16 diff
(96.8 %id)
BF475582 sciatic nerve .c 847 to 1314 469 to 2       468/469
(99 %)
0 diff
(100 %id)
AW150715 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 849 to 1314 476 to 11       466/476
(97 %)
1 diff
(99.8 %id)
AI434060 lymph node, lymphoma, follicular mixed small and largecell .c 851 to 1313 483 to 21   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 463/463
(100 %)
2 diff
(99.6 %id)
AI189383 placenta .c 852 to 1314 470 to 8       463/470
(98 %)
0 diff
(100 %id)
AW780065 colon, moderately-differentiated adenocarcinoma .c 852 to 1314 472 to 10       463/520
(89 %)
12 diff
(97.7 %id)
AW072332 pooled .c 854 to 1314 468 to 4       465/557
(83 %)
14 diff
(97.5 %id)
TI_1948103986   .c 854 to 1287 557 to 124       434/1307
(33 %)
2 diff
(99.9 %id)
DB562364 hypothalamus .c 864 to 1311 2 to 448     Submitted on the opposite strand 447/450
(99 %)
10 diff
(97.8 %id)
BQ002286 Chondrosarcoma, Left Pelvis .c 871 to 1313 461 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 443/443
(100 %)
4 diff
(99.1 %id)
AA430474 ovarian tumor, ovary .c 877 to 1313 436 to 1       436/436
(100 %)
8 diff
(98.2 %id)
BM310461 Pancreas, Purified pancreatic islet .c 887 to 1312 426 to 1       426/426
(100 %)
2 diff
(99.6 %id)
T87884 liver and spleen .c 887 to 1314 427 to 3       425/427
(99 %)
5 diff
(98.9 %id)
AI971391 pooled germ cell tumors .c 887 to 1308 440 to 19   AAA   422/428
(98 %)
3 diff
(99.3 %id)
TI_1948103706   .c 890 to 1287 522 to 123   fully sequenced,   400/522
(76 %)
3 diff
(99.5 %id)
R09558 liver and spleen .c 892 to 1301 410 to 1       410/410
(100 %)
6 diff
(98.6 %id)
AA829969 germinal center B cell .c 905 to 1314 417 to 9       409/417
(98 %)
3 diff
(99.3 %id)
AA635928 invasive tumor (cell line), Prostate .c 908 to 1313 420 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 404/404
(100 %)
4 diff
(99.1 %id)
CB306294 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 922 to 1313 410 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 392/392
(100 %)
2 diff
(99.5 %id)
W81548 heart .c 925 to 1313 387 to 1   fully sequenced,   387/387
(100 %)
9 diff
(97.7 %id)
BE004605 breast_normal .c 928 to 1147 246 to 27     Submitted on the opposite strand 220/247
(89 %)
11 diff
(95.6 %id)
AW804020 uterus .c 929 to 1312 412 to 27       386/412
(93 %)
4 diff
(99.1 %id)
BE178584 head_neck .c 929 to 1312 391 to 9     Submitted on the opposite strand 383/391
(97 %)
2 diff
(99.5 %id)
AW887710 ovary .c 943 to 1307 365 to 1       365/365
(100 %)
2 diff
(99.5 %id)
AL568340 placenta .c 1023 to 1273 252 to 1   fully sequenced,   252/252
(100 %)
19 diff
(92.5 %id)
DA071854 cerebellum .d 1 to 574 2 to 575   tiling clone, capped   574/574
(100 %)
0 diff
(100 %id)
DB297559 cerebellum .d 850 to 1359 511 to 1   tiling clone,   511/511
(100 %)
3 diff
(99.5 %id)
DB104279 thymus .e 1 to 497 2 to 498   tiling clone, capped   497/497
(100 %)
0 diff
(100 %id)
F07750 brain, total brain .e 50 to 316 1 to 267       267/267
(100 %)
4 diff
(98.6 %id)
Z45204 brain, total brain .e 50 to 320 1 to 271       271/271
(100 %)
3 diff
(98.9 %id)
DB342725 thymus .e 1012 to 1592 581 to 1   tiling clone,   581/581
(100 %)
5 diff
(99.2 %id)
Z40834 brain, total brain .e 1307 to 1592 285 to 1       285/285
(100 %)
3 diff
(99.0 %id)
F04088 brain, total brain .e 1336 to 1592 256 to 1   tiling clone,   256/256
(100 %)
3 diff
(98.9 %id)
NM_001128613.1   .f 1 to 1018 1 to 1018 Q234R L237P RefSeq, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 1018/1018
(100 %)
2 diff
(99.9 %id)
BG709126 brain, hypothalamus .f 4 to 664 1 to 661   tiling clone,   661/663
(99 %)
7 diff
(99.0 %id)
BI462113 testis .f 10 to 660 1 to 681       681/690
(98 %)
44 diff
(93.7 %id)
BM831415 stomach .f 14 to 507 1 to 494       494/494
(100 %)
1 diff
(99.8 %id)
BX475539   .f 15 to 608 1 to 592       592/592
(100 %)
4 diff
(99.4 %id)
DB444069 testis .f 16 to 457 1 to 441       441/441
(100 %)
3 diff
(99.4 %id)
CN261713 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 17 to 623 1 to 608       608/608
(100 %)
5 diff
(99.2 %id)
BM045237 carcinoma, cell line, Prostate .f 23 to 653 1 to 631       631/631
(100 %)
1 diff
(99.9 %id)
BX475653   .f 24 to 590 1 to 567       567/567
(100 %)
2 diff
(99.7 %id)
BP213420 cerebrum .f 25 to 596 1 to 573       573/573
(100 %)
9 diff
(98.5 %id)
CR602542 T cells (Jurkat cell line) Cot10-normalized .f 25 to 1010 1 to 986 exact tiling clone,   986/986
(100 %)
0 diff
(100 %id)
BX383484   .f 25 to 1002 1 to 965 L14X L15X G113X R185E E218R ... fully sequenced,   965/965
(100 %)
18 diff
(98.2 %id)
DB469142 hippocampus .f 25 to 465 1 to 438       438/438
(100 %)
8 diff
(98.2 %id)
BM910690 astrocytoma grade IV, cell line, brain .f 27 to 625 1 to 601       601/1159
(51 %)
15 diff
(98.8 %id)
BI752814 brain .f 34 to 660 1 to 629       629/639
(98 %)
1 diff
(99.9 %id)
TI_57214891   .f 34 to 660 29 to 657       629/667
(94 %)
6 diff
(99.2 %id)
BP330134 rectum .f 35 to 623 1 to 587       587/587
(100 %)
5 diff
(99.2 %id)
BE392026 endometrium, adenocarcinoma cell line, uterus .f 44 to 661 1 to 618       618/619
(99 %)
7 diff
(98.9 %id)
CA406504 adipose .f 49 to 653 1 to 605       605/608
(99 %)
15 diff
(97.6 %id)
BE784640 large cell carcinoma, lung .f 53 to 825 1 to 766       766/799
(95 %)
17 diff
(97.9 %id)
BM310766 Pancreas, Purified pancreatic islet .f 58 to 534 1 to 477       477/477
(100 %)
0 diff
(100 %id)
BQ654167 hepatocellular carcinoma, cell line, Liver .f 62 to 850 1 to 788   AAA   788/981
(80 %)
23 diff
(97.7 %id)
BP376713 uterus .f 71 to 635 1 to 565       565/566
(99 %)
12 diff
(97.9 %id)
BQ652592 hepatocellular carcinoma, cell line, Liver .f 72 to 664 25 to 619       595/1050
(56 %)
20 diff
(98.1 %id)
BX282755 pooled brain, lung, testis .f 74 to 427 1 to 354       354/354
(100 %)
0 diff
(100 %id)
CB070105 Pancreas, Purified pancreatic islet .f 74 to 518 1 to 445       445/445
(100 %)
0 diff
(100 %id)
BI521169 pooled pancreas and spleen .f 82 to 724 1 to 644   fully sequenced,   644/644
(100 %)
3 diff
(99.6 %id)
BQ321936 colon .f 123 to 357 1 to 235       235/236
(99 %)
25 diff
(89.5 %id)
CB069620 Pancreas, Purified pancreatic islet .f 683 to 1018 336 to 1   tiling clone,   336/336
(100 %)
2 diff
(99.5 %id)
BI522174 pooled pancreas and spleen .f 694 to 970 273 to 1   fully sequenced,   273/273
(100 %)
8 diff
(97.1 %id)
BX383483   .f 822 to 985 163 to 1   fully sequenced,   163/163
(100 %)
7 diff
(95.8 %id)
BM923060 leukocyte .g 1 to 937 16 to 966 Q227R L230P A259T A260G L261P ... tiling clone,   953/1094
(87 %)
33 diff
(97.0 %id)
BE792998 lung, small cell carcinoma .g 26 to 844 1 to 815       815/881
(92 %)
25 diff
(97.2 %id)
BQ003365 Chondrosarcoma, Left Pelvis .g 210 to 878 688 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 670/670
(100 %)
3 diff
(99.6 %id)
BQ003419 Chondrosarcoma, Left Pelvis .g 249 to 878 648 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 630/630
(100 %)
2 diff
(99.7 %id)
BP428592   .g 301 to 680 1 to 380       380/380
(100 %)
3 diff
(99.3 %id)
CA306208 Alveolar Macrophage, lung .g 325 to 878 572 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 554/554
(100 %)
4 diff
(99.3 %id)
AI971214 Prostate .g 423 to 878 458 to 3       456/458
(99 %)
1 diff
(99.8 %id)
AI685471 Prostate .g 430 to 879 452 to 3   tiling clone,   450/452
(99 %)
0 diff
(100 %id)
N90216 parathyroid gland, parathyroid tumor .g 519 to 878 365 to 1       365/409
(89 %)
12 diff
(97.1 %id)
AI151505 placenta .g 519 to 878 360 to 1       360/362
(99 %)
9 diff
(97.6 %id)
F31659 pectoral muscle (after mastectomy) .g 519 to 845 14 to 338       325/338
(96 %)
9 diff
(97.4 %id)
AW079647 esophagus, squamous cell carcinoma .g 521 to 879 354 to 2       353/410
(86 %)
19 diff
(95.4 %id)
AW887689 ovary .g 522 to 872 15 to 363       349/363
(96 %)
11 diff
(97.0 %id)
AA973593 carcinoid, lung .g 522 to 879 357 to 3       355/357
(99 %)
3 diff
(99.2 %id)
AA371654 pituitary gland .g 524 to 755 1 to 231       231/231
(100 %)
4 diff
(98.3 %id)
BF761445 colon_est .g 532 to 775 262 to 18     Submitted on the opposite strand 245/287
(85 %)
9 diff
(96.9 %id)
AA653072 normal prostate, Prostate .g 539 to 879 339 to 2       338/339
(99 %)
1 diff
(99.8 %id)
F36489 pectoral muscle (after mastectomy) .g 541 to 772 20 to 247       228/247
(92 %)
8 diff
(96.8 %id)
CF530038 placenta .g 546 to 878 351 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 333/333
(100 %)
1 diff
(99.7 %id)
AI422423 brain, glioblastoma (pooled) .g 548 to 878 331 to 1       331/331
(100 %)
2 diff
(99.4 %id)
BE715848 head_neck .g 558 to 775 221 to 4       218/230
(94 %)
0 diff
(100 %id)
BE715852 head_neck .g 558 to 775 223 to 5       219/232
(94 %)
0 diff
(100 %id)
BE715855 head_neck .g 558 to 775 218 to 3       216/227
(95 %)
0 diff
(100 %id)
AI282731 esophagus, squamous cell carcinoma .g 572 to 879 310 to 3       308/310
(99 %)
0 diff
(100 %id)
BF755467 colon .g 591 to 819 234 to 6     Submitted on the opposite strand 229/235
(97 %)
2 diff
(99.2 %id)
AA588856 normal prostate, Prostate .g 591 to 878 288 to 1       288/288
(100 %)
4 diff
(98.7 %id)
AI085132 senescent fibroblast .g 592 to 878 285 to 1       285/285
(100 %)
6 diff
(97.9 %id)
BQ022736 placenta .g 619 to 878 278 to 19   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 260/261
(99 %)
2 diff
(99.3 %id)
AI927397 normal prostate, Prostate .g 621 to 878 258 to 1       258/258
(100 %)
3 diff
(98.9 %id)
AA627660 colon, colon tumor RER+ .g 622 to 877 256 to 1       256/256
(100 %)
7 diff
(97.3 %id)
AA873449 2 pooled tumors (clear cell type), Kidney .g 627 to 813 187 to 1       187/187
(100 %)
2 diff
(99.0 %id)
AA424897 ovarian tumor, ovary .g 633 to 879 1 to 246       246/246
(100 %)
3 diff
(98.8 %id)
BE645736 Prostate .g 655 to 878 224 to 1       224/224
(100 %)
2 diff
(99.2 %id)
CF145731 CNCAP(3)T-225 cell line, Prostate .g 666 to 878 4 to 216   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 213/216
(98 %)
8 diff
(96.3 %id)
AA862408 Kidney .g 667 to 878 226 to 16   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 211/211
(100 %)
5 diff
(97.7 %id)
EC445926 Prostate .g 672 to 775 1 to 104       104/104
(100 %)
2 diff
(98.1 %id)
AI126392 placenta .g 777 to 879 105 to 3       103/105
(98 %)
0 diff
(100 %id)
TI_44342738   .h -9 to 829 84 to 918   tiling clone,   835/928
(89 %)
29 diff
(96.9 %id)
BG714667 brain, hypothalamus .h 1 to 651 8 to 658   tiling clone,   658/658
(100 %)
3 diff
(99.6 %id)
BI666547 brain, hypothalamus .h 1 to 758 8 to 765   tiling clone,   765/842
(90 %)
11 diff
(98.7 %id)
AA280075 germinal center B cell .h 13 to 506 21 to 513       493/513
(96 %)
8 diff
(98.5 %id)
BM913045 amelanotic melanoma, cell line, skin .h 58 to 509 1 to 453       453/1450
(31 %)
11 diff
(99.3 %id)
T84384 liver and spleen .h 63 to 349 1 to 289       289/293
(98 %)
6 diff
(98.0 %id)
AA429427 ovarian tumor, ovary .h 77 to 351 1 to 275       275/275
(100 %)
9 diff
(96.8 %id)
CN261712 embryonic stem cells, cell lines H1, H7, andH9 .h 102 to 325 1 to 224       224/224
(100 %)
1 diff
(99.6 %id)
BF764149 colon_est .h 224 to 381 1 to 158       158/158
(100 %)
3 diff
(98.2 %id)
AA193307 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 292 to 520 1 to 228       228/274
(83 %)
9 diff
(96.8 %id)
BE242795 leukopheresis .h 316 to 488 1 to 173       173/173
(100 %)
4 diff
(97.7 %id)
BG478918 melanotic melanoma, skin .h 318 to 517 8 to 206       199/225
(88 %)
7 diff
(96.9 %id)
AA280046 germinal center B cell .h 869 to 1199 331 to 1   tiling clone,   331/331
(100 %)
1 diff
(99.7 %id)
BG763384 melanotic melanoma, high MDR (cell line), skin .h 885 to 1735 1 to 850       850/850
(100 %)
4 diff
(99.6 %id)
BG767012 melanotic melanoma, high MDR (cell line), skin .h 885 to 1678 1 to 795       795/800
(99 %)
3 diff
(99.7 %id)
AA428223 ovarian tumor, ovary .h 1076 to 1251 176 to 1       176/176
(100 %)
2 diff
(98.9 %id)
BC032137 Pancreas, epithelioid carcinoma .h 1078 to 2091 1 to 1014 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 1014/1014
(100 %)
1 diff
(100.0 %id)
AI640562 Kidney .h 1282 to 1791 1 to 510     Submitted on the opposite strand 510/510
(100 %)
1 diff
(99.9 %id)
BF109948 pooled .h 1556 to 2092 542 to 6   tiling clone,   537/542
(99 %)
0 diff
(100 %id)
BM852571 stomach .h 1582 to 1952 1 to 371       371/371
(100 %)
0 diff
(100 %id)
BI004301 head_normal .h 1604 to 1831 246 to 16       231/246
(93 %)
6 diff
(97.6 %id)
BF761575 colon_est .h 1619 to 1872 277 to 25     Submitted on the opposite strand 253/277
(91 %)
1 diff
(99.7 %id)
AI337329 colon, colon tumor, RER+ .h 1627 to 2091 477 to 13   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 465/465
(100 %)
1 diff
(99.8 %id)
BQ355931 head_neck .h 1660 to 1836 197 to 23       175/197
(88 %)
0 diff
(100 %id)
T69741 liver and spleen .h 1678 to 2020 347 to 4       344/347
(99 %)
1 diff
(99.8 %id)
BM008720 adenocarcinoma, Pancreas .i 1 to 873 1 to 879   tiling clone,   874/982
(89 %)
21 diff
(97.9 %id)
BM044982 carcinoma, cell line, Prostate .i 5 to 906 1 to 897       897/913
(98 %)
15 diff
(98.4 %id)
BQ679602 melanotic melanoma, cell line, skin .i 171 to 901 1 to 737       735/927
(79 %)
15 diff
(98.4 %id)
BG830041 epithelioid carcinoma cell line, Pancreas .i 194 to 1009 1 to 812   available from MGC,   809/1037
(78 %)
18 diff
(98.3 %id)
BM767525 Ascites, stomach .i 213 to 886 1 to 674       674/674
(100 %)
0 diff
(100 %id)
BM767565 Ascites, stomach .i 213 to 921 1 to 710       710/710
(100 %)
1 diff
(99.9 %id)
BM767058 Ascites, stomach .i 213 to 879 1 to 667       667/667
(100 %)
1 diff
(99.9 %id)
BM767118 Ascites, stomach .i 213 to 880 1 to 669       669/669
(100 %)
1 diff
(99.9 %id)
BG325436 Kidney, renal cell adenocarcinoma .i 272 to 1046 1 to 769 S71T L72P H73A S74Q R75P ...     769/910
(84 %)
15 diff
(98.4 %id)
BE560236 Burkitt lymphoma, lymph .i 283 to 886 1 to 605       605/605
(100 %)
3 diff
(99.6 %id)
BC051008 Spleen .i 347 to 1205 1 to 859   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 859/859
(100 %)
0 diff
(100 %id)
BQ706492 Spleen .i 350 to 1194 1 to 850   available from MGC, AAA   850/861
(98 %)
11 diff
(98.8 %id)
BF058544 fibrotheoma, ovary .i 399 to 991 1 to 593     Submitted on the opposite strand 593/593
(100 %)
0 diff
(100 %id)
BI003292 head_normal .i 491 to 938 10 to 458       449/458
(98 %)
7 diff
(98.5 %id)
CA424199 cell lines, Chondrosarcoma .i 554 to 1205 667 to 17   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 651/651
(100 %)
1 diff
(99.9 %id)
BQ773782 Chondrosarcoma Grade II, Left Pelvis .i 575 to 1205 644 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 626/626
(100 %)
6 diff
(99.1 %id)
BM689143 eye, optic nerve .j 1 to 500 5 to 504   tiling clone, Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 500/504
(99 %)
6 diff
(98.9 %id)
BU727364 eye, optic nerve .j 953 to 1293 359 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 341/341
(100 %)
1 diff
(99.8 %id)
BU171233 leiomyosarcoma, uterus .k 1 to 790 1 to 792   tiling clone,   792/893
(88 %)
8 diff
(99.2 %id)
CR982830 T-Lymphocytes .k 761 to 1401 1 to 641   tiling clone,   641/643
(99 %)
3 diff
(99.6 %id)
AW978517   .k 1013 to 1648 642 to 7     Submitted on the opposite strand 636/756
(84 %)
0 diff
(100 %id)
BG699254 brain, hippocampus .k 1102 to 1775 1 to 673       673/673
(100 %)
9 diff
(98.7 %id)
BC044584 Brain, hippocampus .k 1107 to 2393 1 to 1287 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 1287/1287
(100 %)
2 diff
(99.9 %id)
BC053947.
matches multiple genes
brain, Brain, hippocampus, hippocampus .k 1107 to 2393 1 to 1287   available from MGC, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base), also hits gene ARPC3andANAPC7 1287/1287
(100 %)
2 diff
(99.9 %id)
NM_005528.3   .k 1110 to 2393 1 to 1284 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 1284/1284
(100 %)
0 diff
(100 %id)
AA504260 germinal center B cell .k 1126 to 1571 442 to 1       442/442
(100 %)
7 diff
(98.5 %id)
CB988417 Human Placenta, placenta .k 1192 to 1930 28 to 774       747/800
(93 %)
26 diff
(96.8 %id)
BM724189 eye, fetal eye .k 1248 to 1782 1 to 536   fully sequenced, Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 536/536
(100 %)
0 diff
(100 %id)
BM848487 myeloma .k 1265 to 1700 1 to 436       436/436
(100 %)
5 diff
(98.9 %id)
DB473155 hippocampus .k 1271 to 1742 1 to 472       472/472
(100 %)
3 diff
(99.4 %id)
BC057849 Placenta, pre-eclamptic .k 1277 to 2393 1 to 1117 exact available from MGC, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 1117/1117
(100 %)
2 diff
(99.9 %id)
BE264569 lung, small cell carcinoma .k 1282 to 1933 1 to 652   AAA   652/713
(91 %)
7 diff
(99.1 %id)
BG386039 adenocarcinoma cell line, colon .k 1282 to 2099 1 to 822       822/867
(94 %)
21 diff
(97.6 %id)
BG769325 melanotic melanoma, high MDR (cell line), skin .k 1282 to 2099 1 to 822       819/832
(98 %)
8 diff
(99.1 %id)
TI_59386430   .k 1282 to 2238 101 to 1069       964/981
(98 %)
36 diff
(96.4 %id)
DB480740 hippocampus .k 1284 to 1739 1 to 454       454/454
(100 %)
3 diff
(99.4 %id)
CN368342 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 1285 to 1810 1 to 526       526/526
(100 %)
2 diff
(99.7 %id)
BG749944 eye, normal pigmented retinal epithelium .k 1285 to 2104 1 to 816       813/1042
(78 %)
17 diff
(98.4 %id)
BG750263 eye, normal pigmented retinal epithelium .k 1285 to 2075 1 to 789       789/789
(100 %)
3 diff
(99.7 %id)
BU539083 adenocarcinoma, cell line, breast .k 1287 to 2045 1 to 763       763/1037
(73 %)
12 diff
(98.9 %id)
CA406921 adipose .k 1289 to 1873 1 to 587       587/587
(100 %)
5 diff
(99.2 %id)
BG713905 brain, hypothalamus .k 1290 to 2118 1 to 835       835/835
(100 %)
26 diff
(96.9 %id)
DB491898 hypothalamus .k 1303 to 1718 1 to 415       415/415
(100 %)
11 diff
(97.4 %id)
BE512676 adenocarcinoma cell line, colon .k 1304 to 1981 1 to 710       707/1334
(52 %)
43 diff
(96.8 %id)
BG747969 eye, normal pigmented retinal epithelium .k 1306 to 2099 1 to 795       795/801
(99 %)
18 diff
(97.8 %id)
BG750576 eye, normal pigmented retinal epithelium .k 1306 to 1883 1 to 584       584/584
(100 %)
10 diff
(98.3 %id)
TI_154194270   .k 1465 to 2299 32 to 863 R65L Q148H E188G A195V A200C ...     832/1036
(80 %)
38 diff
(96.4 %id)
BM755954 Ascites, stomach .k 1493 to 2100 1 to 609       609/609
(100 %)
7 diff
(98.9 %id)
BM767554 Ascites, stomach .k 1493 to 2029 1 to 537       537/537
(100 %)
8 diff
(98.6 %id)
BM767456 Ascites, stomach .k 1493 to 2049 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BM766691 Ascites, stomach .k 1493 to 1751 1 to 259       259/266
(97 %)
2 diff
(99.3 %id)
AF036874   .k 1503 to 2394 1 to 892 exact tiling clone,   892/892
(100 %)
0 diff
(100 %id)
TI_1948155653   .k 1571 to 1861 137 to 427       291/318
(91 %)
6 diff
(98.2 %id)
TI_1948155815   .k 1571 to 1824 138 to 391   fully sequenced,   254/281
(90 %)
6 diff
(97.9 %id)
TI_1948155984   .k 1571 to 1845 140 to 414       275/302
(91 %)
6 diff
(98.1 %id)
TI_1948156147   .k 1571 to 1782 139 to 350   fully sequenced,   212/239
(88 %)
6 diff
(97.5 %id)
EL734001 mixed .k 1572 to 2232 1 to 661       661/661
(100 %)
0 diff
(100 %id)
TI_149302995   .k 1583 to 2393 885 to 85   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 801/929
(86 %)
16 diff
(98.3 %id)
AA974070 pooled germ cell tumors .k 1641 to 2085 1 to 444     Submitted on the opposite strand 444/444
(100 %)
2 diff
(99.6 %id)
AW015041   .k 1642 to 1994 1 to 354     Submitted on the opposite strand 354/354
(100 %)
8 diff
(97.8 %id)
AA448128   .k 1657 to 2035 1 to 379   fully sequenced,   379/379
(100 %)
1 diff
(99.8 %id)
CA314993 Human Lung Epithelial cells, lung .k 1657 to 2393 752 to 17   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 736/738
(99 %)
2 diff
(99.8 %id)
AI192962 lung .k 1658 to 2178 1 to 520     Submitted on the opposite strand 520/520
(100 %)
1 diff
(99.9 %id)
BM981091 lung, Primary Lung Cystic Fibrosis EpithelialCells .k 1658 to 2393 750 to 17   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 734/742
(98 %)
3 diff
(99.6 %id)
AI393201 B-cell, chronic lymphotic leukemia .k 1660 to 2179 1 to 520     Submitted on the opposite strand 520/520
(100 %)
0 diff
(100 %id)
AI306551 carcinoid, lung .k 1665 to 2099 1 to 435     Submitted on the opposite strand 435/435
(100 %)
3 diff
(99.4 %id)
AI560754 anaplastic oligodendroglioma, brain .k 1665 to 2099 1 to 435     Submitted on the opposite strand 435/435
(100 %)
6 diff
(98.7 %id)
AI568950 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .k 1665 to 2097 1 to 433     Submitted on the opposite strand 433/435
(99 %)
7 diff
(98.4 %id)
AA781044 parathyroid gland, parathyroid tumor .k 1679 to 1933 1 to 255     Submitted on the opposite strand 255/255
(100 %)
1 diff
(99.7 %id)
N30776 placenta .k 1679 to 2157 1 to 482     Submitted on the opposite strand 480/482
(99 %)
13 diff
(97.4 %id)
AA554878 breast .k 1679 to 1918 1 to 240     Submitted on the opposite strand 240/240
(100 %)
0 diff
(100 %id)
AA569953 breast .k 1679 to 2159 1 to 479     Submitted on the opposite strand 479/479
(100 %)
4 diff
(99.2 %id)
AA724072 pooled .k 1679 to 2099 1 to 421     Submitted on the opposite strand 421/436
(96 %)
4 diff
(99.1 %id)
AA962627 Kidney .k 1679 to 2099 1 to 420     Submitted on the opposite strand 420/420
(100 %)
1 diff
(99.8 %id)
AA974630 pooled .k 1679 to 2177 1 to 498     Submitted on the opposite strand 498/498
(100 %)
2 diff
(99.6 %id)
AI369269 anaplastic oligodendroglioma, brain .k 1679 to 2090 1 to 412     Submitted on the opposite strand 412/412
(100 %)
0 diff
(100 %id)
AI568370 B-cell, chronic lymphotic leukemia .k 1679 to 2154 1 to 476     Submitted on the opposite strand 476/476
(100 %)
0 diff
(100 %id)
AI678242 Kidney .k 1679 to 2095 1 to 417     Submitted on the opposite strand 417/421
(99 %)
6 diff
(98.6 %id)
AI673611 colon, colonic mucosa from 3 patients with Crohn'sdisease .k 1679 to 1976 1 to 298     Submitted on the opposite strand 298/298
(100 %)
12 diff
(96.0 %id)
AW071719 anaplastic oligodendroglioma, brain .k 1679 to 2157 1 to 472     Submitted on the opposite strand 475/472
(100 %)
13 diff
(97.3 %id)
AW028674 fibrotheoma, ovary .k 1679 to 2218 1 to 540     Submitted on the opposite strand 540/541
(99 %)
8 diff
(98.6 %id)
BE502689 pooled germ cell tumors .k 1679 to 2294 1 to 616     Submitted on the opposite strand 616/616
(100 %)
4 diff
(99.4 %id)
BE646073 B-cell, chronic lymphotic leukemia .k 1679 to 2294 1 to 616     Submitted on the opposite strand 616/616
(100 %)
10 diff
(98.4 %id)
AW024467 Kidney .k 1689 to 2261 1 to 573     Submitted on the opposite strand 573/582
(98 %)
9 diff
(98.5 %id)
BF196177 carcinoid, lung .k 1694 to 2270 1 to 577     Submitted on the opposite strand 577/577
(100 %)
13 diff
(97.8 %id)
TI_1948156148   .k 1721 to 2303 701 to 117   fully sequenced,   585/701
(83 %)
8 diff
(98.9 %id)
BM680347 eye, fetal eye .k 1721 to 2393 687 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 671/671
(100 %)
1 diff
(99.9 %id)
AA736465 germinal center B cell .k 1739 to 2119 1 to 376     Submitted on the opposite strand 376/380
(98 %)
8 diff
(97.9 %id)
AA969957 pooled .k 1739 to 1858 1 to 120     Submitted on the opposite strand 120/121
(99 %)
3 diff
(97.6 %id)
BQ000095 Fibrosarcoma .k 1741 to 2393 669 to 17   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 653/653
(100 %)
0 diff
(100 %id)
TI_154023139   .k 1743 to 2393 738 to 88   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 651/659
(98 %)
8 diff
(98.8 %id)
CD367853 Alveolar Macrophage, lung .k 1745 to 2393 667 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
BQ017462 lung, Metastatic Chondrosarcoma .k 1746 to 2393 664 to 17   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 648/648
(100 %)
0 diff
(100 %id)
BE467596 carcinoid, lung .k 1749 to 2394 652 to 5       645/665
(96 %)
31 diff
(95.4 %id)
AA854160 parathyroid gland, parathyroid tumor .k 1750 to 2039 12 to 300     Submitted on the opposite strand 286/300
(95 %)
9 diff
(97.0 %id)
AI560034 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .k 1750 to 2090 17 to 356     Submitted on the opposite strand 340/356
(95 %)
13 diff
(96.4 %id)
AW197468 pooled germ cell tumors .k 1750 to 2077 69 to 397     Submitted on the opposite strand 329/397
(82 %)
20 diff
(95.0 %id)
BQ446247 Knee, Osteoarthritic Cartilage .k 1750 to 2393 659 to 17   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 643/643
(100 %)
4 diff
(99.4 %id)
AA897216 pooled .k 1751 to 2044 1 to 295     Submitted on the opposite strand 295/295
(100 %)
29 diff
(90.2 %id)
AI343522 colon, colon tumor, RER+ .k 1751 to 1901 1 to 151     Submitted on the opposite strand 151/151
(100 %)
12 diff
(92.1 %id)
BF110698 carcinoid, lung .k 1751 to 2090 1 to 343     Submitted on the opposite strand 340/343
(99 %)
7 diff
(98.0 %id)
AI761257 2 pooled tumors (clear cell type), Kidney .k 1758 to 2383 640 to 15       626/640
(97 %)
0 diff
(100 %id)
BM686355 eye, eye anterior segment .k 1760 to 2342 13 to 596       584/596
(97 %)
6 diff
(99.0 %id)
AA326970 colon .k 1763 to 2005 1 to 243       243/243
(100 %)
0 diff
(100 %id)
BQ359763 head_normal .k 1771 to 1971 26 to 226       201/230
(87 %)
10 diff
(95.7 %id)
BQ356200 head_neck .k 1778 to 2180 430 to 29       402/430
(93 %)
0 diff
(100 %id)
TI_1948155816   .k 1794 to 2303 625 to 116   fully sequenced,   510/625
(81 %)
5 diff
(99.2 %id)
BM708588 eye, RPE and Choroid .k 1810 to 2306 1 to 497       497/497
(100 %)
0 diff
(100 %id)
BE464224 Kidney .k 1814 to 2394 585 to 1       582/664
(87 %)
22 diff
(96.7 %id)
CA439355 lung, Metastatic Chondrosarcoma .k 1822 to 2393 588 to 17   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 572/572
(100 %)
1 diff
(99.9 %id)
AA929010 pooled .k 1830 to 2394 558 to 5       554/558
(99 %)
20 diff
(96.5 %id)
AI478352 Kidney .k 1860 to 2097 238 to 1       238/238
(100 %)
11 diff
(95.4 %id)
AI916741 Kidney .k 1863 to 2392 535 to 7       529/535
(98 %)
1 diff
(99.9 %id)
BG413564 pooled .k 1863 to 2394 540 to 9       532/540
(98 %)
3 diff
(99.5 %id)
BF063080 colon, colon tumor, RER+ .k 1866 to 2394 531 to 3       529/531
(99 %)
0 diff
(100 %id)
BG413543 pooled .k 1866 to 2394 537 to 9       529/537
(98 %)
0 diff
(100 %id)
AW268619 pooled .k 1869 to 2388 525 to 6       520/525
(99 %)
5 diff
(99.1 %id)
AA524179 colon .k 1882 to 2394 518 to 5       511/518
(98 %)
11 diff
(97.9 %id)
AI685161 pooled .k 1883 to 2394 515 to 5       511/515
(99 %)
6 diff
(98.9 %id)
AI806393 pooled .k 1899 to 2394 498 to 3       496/498
(99 %)
3 diff
(99.4 %id)
BP387345 pancreatic islet .k 1900 to 2384 1 to 485     Submitted on the opposite strand 485/489
(99 %)
2 diff
(99.6 %id)
AI198601   .k 1903 to 2394 495 to 4       492/495
(99 %)
0 diff
(100 %id)
CN265605 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 1904 to 2393 541 to 52   AAA Submitted on the opposite strand 490/490
(100 %)
7 diff
(98.6 %id)
BQ268041 insulinoma, Pancreas .k 1904 to 2129 1 to 226   fully sequenced,   226/226
(100 %)
5 diff
(97.8 %id)
TI_1948155654   .k 1905 to 2303 515 to 117       399/419
(95 %)
5 diff
(98.9 %id)
AW592413 pooled .k 1914 to 2393 493 to 15   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 479/479
(100 %)
5 diff
(99.0 %id)
AA828364 germinal center B cell .k 1923 to 2349 427 to 1       427/428
(99 %)
9 diff
(97.9 %id)
AA921825 pooled .k 1923 to 2350 425 to 1       425/425
(100 %)
15 diff
(96.5 %id)
BF433222 carcinoid, lung .k 1928 to 2394 472 to 6       467/472
(98 %)
0 diff
(100 %id)
AI703285 carcinoid, lung .k 1929 to 2393 465 to 1       465/465
(100 %)
1 diff
(99.8 %id)
BE326383 carcinoid, lung .k 1929 to 2393 465 to 1       465/465
(100 %)
2 diff
(99.6 %id)
BM676819 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .k 1932 to 2393 478 to 17   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 462/468
(98 %)
4 diff
(99.2 %id)
AI678931 Prostate .k 1934 to 2394 462 to 5       458/467
(98 %)
5 diff
(99.0 %id)
BM719969 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .k 1934 to 2394 1 to 460       460/462
(99 %)
5 diff
(99.0 %id)
AI700574 carcinoid, lung .k 1935 to 2394 461 to 2       460/461
(99 %)
0 diff
(100 %id)
TI_1948155985   .k 1937 to 2303 483 to 117       367/387
(94 %)
5 diff
(98.8 %id)
BF110395 carcinoid, lung .k 1938 to 2394 460 to 4       457/460
(99 %)
0 diff
(100 %id)
AW754433 colon .k 1940 to 2110 5 to 174       170/174
(97 %)
12 diff
(93.2 %id)
AW250031 lung, small cell carcinoma .k 1944 to 2393 460 to 11   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 450/450
(100 %)
0 diff
(100 %id)
AI005093 pooled .k 1945 to 2393 460 to 15   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 446/447
(99 %)
8 diff
(98.3 %id)
AI342953 carcinoid, lung .k 1947 to 2394 449 to 2       448/449
(99 %)
3 diff
(99.4 %id)
AI632905 carcinoid, lung .k 1947 to 2393 447 to 1       447/447
(100 %)
2 diff
(99.6 %id)
BU727917 eye, optic nerve .k 1947 to 2393 465 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 447/452
(98 %)
2 diff
(99.6 %id)
AI819894 2 pooled tumors (clear cell type), Kidney .k 1948 to 2394 451 to 6       446/451
(98 %)
7 diff
(98.5 %id)
AI698041 carcinoid, lung .k 1951 to 2394 445 to 2       444/445
(99 %)
0 diff
(100 %id)
AI142608 pooled .k 1953 to 2393 438 to 1       438/438
(100 %)
17 diff
(96.2 %id)
AA758650   .k 1954 to 2394 440 to 4       437/440
(99 %)
5 diff
(98.9 %id)
AI300959 carcinoid, lung .k 1956 to 2393 438 to 1       438/438
(100 %)
2 diff
(99.6 %id)
AI066771   .k 1959 to 2394 438 to 3       436/438
(99 %)
0 diff
(100 %id)
BF589399 pooled .k 1965 to 2394 435 to 6       430/435
(98 %)
0 diff
(100 %id)
BU739822 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .k 1967 to 2394 445 to 18       428/445
(96 %)
1 diff
(99.8 %id)
AA909741 pooled .k 1969 to 2097 129 to 1       129/130
(99 %)
6 diff
(95.4 %id)
AI749898 colon .k 1969 to 2391 423 to 1       423/423
(100 %)
0 diff
(100 %id)
AW242478 Kidney .k 1974 to 2393 420 to 1       420/420
(100 %)
5 diff
(98.9 %id)
AA620824   .k 1990 to 2394 406 to 3       404/406
(99 %)
2 diff
(99.6 %id)
AA843680 parathyroid gland, parathyroid tumor .k 1990 to 2394 409 to 6       404/409
(98 %)
2 diff
(99.6 %id)
AA813905 germinal center B cell .k 1995 to 2349 351 to 1       351/355
(98 %)
9 diff
(97.5 %id)
AA725316 parathyroid gland, parathyroid tumor .k 1997 to 2394 401 to 6       396/401
(98 %)
1 diff
(99.8 %id)
AI590811 ovary, tumor, 5 pooled (see description) .k 1998 to 2393 412 to 17   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 396/396
(100 %)
2 diff
(99.5 %id)
AA868814 pooled .k 2004 to 2393 397 to 14   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 384/384
(100 %)
8 diff
(98.0 %id)
AA447986   .k 2005 to 2394 389 to 3   fully sequenced,   387/389
(99 %)
2 diff
(99.5 %id)
BF109276 pooled .k 2013 to 2292 280 to 1       280/280
(100 %)
3 diff
(99.0 %id)
AA830392 germinal center B cell .k 2015 to 2349 335 to 1       335/335
(100 %)
9 diff
(97.4 %id)
AA912435 pooled .k 2016 to 2352 338 to 1       338/338
(100 %)
10 diff
(97.1 %id)
DB510065 testis .k 2024 to 2393 1 to 370     Submitted on the opposite strand 370/370
(100 %)
8 diff
(97.9 %id)
BF000423 colon, colon tumor, RER+ .k 2053 to 2187 135 to 1       135/136
(99 %)
2 diff
(98.6 %id)
BM148586 leukopheresis .k 2057 to 2391 351 to 17   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 335/335
(100 %)
6 diff
(98.3 %id)
BQ267791 insulinoma, Pancreas .k 2068 to 2366 299 to 1   fully sequenced,   299/299
(100 %)
0 diff
(100 %id)
AA812585   .k 2072 to 2387 315 to 1       315/315
(100 %)
4 diff
(98.8 %id)
AA917415 pooled .k 2085 to 2393 303 to 1       303/303
(100 %)
10 diff
(96.7 %id)
AW384478 head_neck .k 2096 to 2367 1 to 272       272/272
(100 %)
0 diff
(100 %id)
AW384485 head_neck .k 2096 to 2367 1 to 272       272/272
(100 %)
0 diff
(100 %id)
AW384523 head_neck .k 2096 to 2367 1 to 272       272/272
(100 %)
0 diff
(100 %id)
AA766154 germinal center B cell .k 2182 to 2393 225 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 207/207
(100 %)
7 diff
(96.7 %id)
AI810421 Prostate .k 2182 to 2393 212 to 1       212/219
(96 %)
1 diff
(99.6 %id)
AI701358 Prostate .k 2182 to 2356 175 to 1       175/182
(96 %)
1 diff
(99.5 %id)
AK308555 cerebellum .l 1 to 985 2 to 986 S197P F198S tiling clone,   986/986
(100 %)
3 diff
(99.7 %id)
BM046048 carcinoma, cell line, Prostate .m 1 to 867 1 to 877   tiling clone,   874/877
(99 %)
20 diff
(97.8 %id)
DR007088 Spleen .m 85 to 798 8 to 720       713/720
(99 %)
7 diff
(99.1 %id)
TI_157605629   .m 357 to 1205 59 to 912 A181G R182K Q190P R198A Q199E ... tiling clone, Submitted on the opposite strand 854/973
(87 %)
37 diff
(96.2 %id)
AW366597 head_neck .m 444 to 733 292 to 2       291/299
(97 %)
1 diff
(99.7 %id)
CB047118 2 pooled tumors (clear cell type), Kidney .m 472 to 989 6 to 522   fully sequenced, Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 517/522
(99 %)
7 diff
(98.7 %id)
CB047117 2 pooled tumors (clear cell type), Kidney .m 959 to 1225 315 to 49   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 267/267
(100 %)
8 diff
(97.1 %id)
BG112478 Bone, osteosarcoma, cell line .n 1 to 687 1 to 685 E10D L15A Q16A C17V G19W ... tiling clone,   685/895
(76 %)
17 diff
(98.2 %id)
BI668177 brain, hypothalamus .o 1 to 885 1 to 888 H118T Q119K T120H H121T S122A ... tiling clone,   888/890
(99 %)
26 diff
(97.1 %id)
TI_44346319   .o 4 to 885 84 to 968 H118T Q119K T120H H121T S122A ...     885/970
(91 %)
28 diff
(97.2 %id)
AI802132 carcinoid, lung .o 376 to 855 1 to 480     Submitted on the opposite strand 480/480
(100 %)
1 diff
(99.8 %id)
AI122792 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .o 385 to 989 605 to 1   tiling clone,   605/605
(100 %)
1 diff
(99.9 %id)
BE348750 carcinoid, lung .o 390 to 921 1 to 532     Submitted on the opposite strand 532/532
(100 %)
0 diff
(100 %id)
BF433833 carcinoid, lung .o 404 to 922 1 to 519     Submitted on the opposite strand 519/519
(100 %)
0 diff
(100 %id)
BF444913 carcinoid, lung .o 535 to 990 458 to 3       453/458
(98 %)
0 diff
(100 %id)
CA433750 mixed .o 560 to 986 445 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 427/427
(100 %)
0 diff
(100 %id)
AW594359 pooled germ cell tumors .o 611 to 989 382 to 1       382/386
(98 %)
6 diff
(98.5 %id)
AA455339 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .o 634 to 978 345 to 3       340/345
(98 %)
0 diff
(100 %id)
AI289044 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .o 680 to 986 307 to 1       307/307
(100 %)
1 diff
(99.7 %id)
AI468673 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .o 685 to 989 306 to 1       306/409
(74 %)
5 diff
(98.8 %id)
AA533976 normal prostatic epithelial cells, Prostate .o 768 to 989 8 to 230   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 223/230
(96 %)
6 diff
(97.4 %id)
BF088765 head_neck .p 1 to 250 266 to 16   tiling clone,   251/266
(94 %)
2 diff
(99.3 %id)
BF432077 pooled .p 92 to 631 1 to 540   tiling clone, Submitted on the opposite strand 540/541
(99 %)
1 diff
(99.9 %id)
BQ447912 Knee, Osteoarthritic Cartilage .p 335 to 809 491 to 17   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 475/475
(100 %)
0 diff
(100 %id)
DB541916 hippocampus .p 343 to 809 1 to 465     Submitted on the opposite strand 465/465
(100 %)
4 diff
(99.2 %id)
AI682504 Prostate .p 350 to 810 465 to 4       462/517
(89 %)
6 diff
(98.9 %id)
BE464527 carcinoid, lung .p 350 to 809 460 to 1       460/468
(98 %)
8 diff
(98.3 %id)
BE467553 carcinoid, lung .p 350 to 810 465 to 6   tiling clone,   460/466
(98 %)
1 diff
(99.8 %id)
BF437905 carcinoid, lung .p 350 to 810 464 to 4       461/490
(94 %)
5 diff
(99.0 %id)
AA987595 carcinoid, lung .p 356 to 810 454 to 2       453/491
(92 %)
7 diff
(98.6 %id)
AI814643 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .q 1 to 502 1 to 503 Q81P L82V R83E Q84A Q85A ... tiling clone, Submitted on the opposite strand 503/503
(100 %)
1 diff
(99.9 %id)
AI078588 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .r 1 to 489 1 to 489 K132X tiling clone, Submitted on the opposite strand 489/489
(100 %)
0 diff
(100 %id)
AI368785 lung .s 1 to 431 1 to 431   tiling clone, Submitted on the opposite strand 431/431
(100 %)
0 diff
(100 %id)
AI424276 Prostate .s 190 to 722 533 to 1   tiling clone,   533/533
(100 %)
0 diff
(100 %id)
BE645409 Prostate .s 190 to 722 543 to 11   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 533/533
(100 %)
2 diff
(99.7 %id)
AA514603 colon .t 1 to 474 485 to 15 D29T L30S P32H H34T P35L ... tiling clone, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 471/471
(100 %)
6 diff
(98.8 %id)
AI018504 breast .t 93 to 475 383 to 1   tiling clone,   383/383
(100 %)
2 diff
(99.5 %id)
AI201571 heart .t 97 to 475 380 to 2       379/380
(99 %)
0 diff
(100 %id)
N95246 lung .u-u 1 to 354 1 to 347   tiling clone, Submitted on the opposite strand 347/369
(94 %)
15 diff
(96.0 %id)
AK091796 lung .u-u 61 to 2196 2137 to 1 exact tiling clone, available from FLJ, Submitted on the opposite strand 2137/2137
(100 %)
6 diff
(99.8 %id)
AX747192   .u-u 61 to 2196 2137 to 1 exact   Submitted on the opposite strand 2137/2137
(100 %)
6 diff
(99.8 %id)
DB319330 lung .u-u 61 to 597 1 to 537     Submitted on the opposite strand 537/537
(100 %)
0 diff
(100 %id)
TI_149298304   .u-u 161 to 923 837 to 76   AAA   762/793
(96 %)
7 diff
(99.2 %id)
BM983066 lung, Primary Lung Cystic Fibrosis EpithelialCells .u-u 211 to 923 728 to 19   AAA   710/710
(100 %)
5 diff
(99.3 %id)
AA186373   .u-u 245 to 581 338 to 1     Submitted on the opposite strand 338/338
(100 %)
4 diff
(98.9 %id)
BQ011069 placenta .u-u 325 to 923 617 to 19   AAA   599/600
(99 %)
8 diff
(98.7 %id)
AI934286 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .u-u 558 to 924 372 to 2       371/372
(99 %)
0 diff
(100 %id)
BI561547 testis .u-u 1221 to 1811 1 to 598       598/605
(98 %)
26 diff
(95.8 %id)
TI_44350766   .u-u 1226 to 1811 128 to 720       593/727
(81 %)
23 diff
(96.9 %id)
BI561130 testis .u-u 1229 to 1780 1 to 552       552/553
(99 %)
5 diff
(99.1 %id)
DB445081 testis .u-u 1230 to 1651 1 to 421       421/426
(98 %)
10 diff
(97.7 %id)
TI_44348808   .u-u 1234 to 1780 89 to 635       547/636
(86 %)
2 diff
(99.7 %id)
AW450435   .u-u 1237 to 1344 124 to 17   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 108/134
(80 %)
0 diff
(100 %id)
BF509055   .u-u 1237 to 1838 602 to 1       602/612
(98 %)
0 diff
(100 %id)
BF116164 fibrotheoma, ovary .u-u 1238 to 1812 574 to 1       574/574
(100 %)
1 diff
(99.9 %id)
AA393996   .u-u 1267 to 1703 1 to 432       432/432
(100 %)
9 diff
(98.0 %id)
BF059090 fibrotheoma, ovary .u-u 1306 to 1839 534 to 1   tiling clone,   534/534
(100 %)
0 diff
(100 %id)
BF116154 fibrotheoma, ovary .u-u 1320 to 1802 483 to 1       483/486
(99 %)
0 diff
(100 %id)
AW027131 thymus, pooled .u-u 1338 to 1812 475 to 1       475/475
(100 %)
4 diff
(99.2 %id)
AA825393 germinal center B cell .u-u 1356 to 1748 390 to 1       390/390
(100 %)
8 diff
(98.0 %id)
BE675994 B-cell, chronic lymphotic leukemia .u-u 1361 to 1839 479 to 1       479/479
(100 %)
0 diff
(100 %id)
AI363182 anaplastic oligodendroglioma, brain .u-u 1364 to 1812 449 to 1       449/449
(100 %)
0 diff
(100 %id)
AW028786 fibrotheoma, ovary .u-u 1369 to 1812 445 to 1       445/445
(100 %)
1 diff
(99.8 %id)
AI190323   .u-u 1379 to 1821 443 to 1       443/443
(100 %)
1 diff
(99.8 %id)
AI801537 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .u-u 1388 to 1839 453 to 2       452/453
(99 %)
0 diff
(100 %id)
AA609621   .u-u 1389 to 1812 423 to 1       423/423
(100 %)
2 diff
(99.6 %id)
AI381443 B-cell, chronic lymphotic leukemia .u-u 1417 to 1812 396 to 1       396/396
(100 %)
0 diff
(100 %id)
AA515027 colon .u-u 1436 to 1839 401 to 1       401/401
(100 %)
7 diff
(98.3 %id)
AI453833 pooled .u-u 1438 to 1812 375 to 1       375/375
(100 %)
0 diff
(100 %id)
AI738998 colon, colon tumor, RER+ .u-u 1440 to 1812 373 to 1       373/373
(100 %)
0 diff
(100 %id)
AI885155 anaplastic oligodendroglioma, brain .u-u 1444 to 1812 369 to 1       369/369
(100 %)
0 diff
(100 %id)
AA768363 germinal center B cell .u-u 1454 to 1739 286 to 1       286/286
(100 %)
3 diff
(99.0 %id)
AI566957 anaplastic oligodendroglioma, brain .u-u 1461 to 1839 378 to 1       378/378
(100 %)
2 diff
(99.5 %id)
DB445046 testis .u-u 1462 to 1686 1 to 225       225/226
(99 %)
11 diff
(95.2 %id)
AA340044 epithelium, skin .u-u 1473 to 1664 1 to 192       192/192
(100 %)
0 diff
(100 %id)
CD674781 eye, lens .u-u 1474 to 1831 1 to 358       358/358
(100 %)
0 diff
(100 %id)
BI762312 pooled colon, kidney, stomach .u-u 1474 to 1831 1 to 358       358/358
(100 %)
0 diff
(100 %id)
BM714130 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .u-u 1475 to 1830 1 to 356       356/356
(100 %)
0 diff
(100 %id)
AA279481 germinal center B cell .u-u 1477 to 1839 363 to 1       363/363
(100 %)
5 diff
(98.7 %id)
BI763085 pooled colon, kidney, stomach .u-u 1478 to 1831 1 to 354       354/354
(100 %)
2 diff
(99.5 %id)
AW452349   .u-u 1493 to 1838 346 to 1       346/356
(97 %)
0 diff
(100 %id)
AA996059 breast .u-u 1494 to 1812 319 to 1       319/319
(100 %)
1 diff
(99.7 %id)
AI536951 anaplastic oligodendroglioma, brain .u-u 1495 to 1812 318 to 1       318/318
(100 %)
0 diff
(100 %id)
AW024633 Kidney .u-u 1499 to 1821 325 to 1       325/325
(100 %)
8 diff
(97.6 %id)
AA627839 colon, colon tumor RER+ .u-u 1501 to 1812 312 to 1       312/312
(100 %)
3 diff
(99.1 %id)
BF194754 fibrotheoma, ovary .u-u 1501 to 1796 297 to 1       297/297
(100 %)
7 diff
(97.7 %id)
AI208107   .u-u 1506 to 1839 334 to 1       334/334
(100 %)
0 diff
(100 %id)
AI768400 Kidney .u-u 1506 to 1749 244 to 1       244/244
(100 %)
5 diff
(98.0 %id)
AI015916   .u-u 1508 to 1839 332 to 1       332/332
(100 %)
0 diff
(100 %id)
BI964717 Islets of Langerhans, Pancreas .u-u 1508 to 1831 1 to 323       323/323
(100 %)
7 diff
(97.9 %id)
AA996013 2 pooled tumors (clear cell type), Kidney .u-u 1510 to 1812 303 to 1       303/303
(100 %)
1 diff
(99.7 %id)
AI189962 placenta .u-u 1510 to 1812 303 to 1       303/303
(100 %)
2 diff
(99.4 %id)
AA969823 2 pooled tumors (clear cell type), Kidney .u-u 1511 to 1812 303 to 1       303/303
(100 %)
3 diff
(99.1 %id)
AA736877 germinal center B cell .u-u 1512 to 1752 241 to 1       241/241
(100 %)
0 diff
(100 %id)
AA397718   .u-u 1516 to 1601 9 to 93   fully sequenced,   85/93
(91 %)
7 diff
(92.5 %id)
N37043 melanocyte .u-u 1520 to 1812 288 to 1       288/297
(96 %)
7 diff
(97.7 %id)
BX117985   .u-u 1522 to 1834 1 to 314       314/317
(99 %)
3 diff
(99.1 %id)
AA614468 breast .u-u 1522 to 1749 228 to 1       228/239
(95 %)
1 diff
(99.6 %id)
AI150304   .u-u 1522 to 1812 291 to 1       291/291
(100 %)
0 diff
(100 %id)
AI128317 placenta .u-u 1526 to 1812 287 to 1       287/287
(100 %)
0 diff
(100 %id)
AA470838 colon .u-u 1529 to 1812 284 to 1       284/284
(100 %)
6 diff
(97.9 %id)
AI492221 B-cell, chronic lymphotic leukemia .u-u 1529 to 1821 293 to 1       293/293
(100 %)
0 diff
(100 %id)
AI055802 anaplastic oligodendroglioma, brain .u-u 1532 to 1839 305 to 1       305/305
(100 %)
4 diff
(98.7 %id)
EC485911 Prostate .u-u 1548 to 1663 116 to 2       115/116
(99 %)
0 diff
(100 %id)
BM717670 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .u-u 1555 to 1830 1 to 276       276/276
(100 %)
3 diff
(99.0 %id)
BF002526 colon, colon tumor, RER+ .u-u 1566 to 1821 256 to 1       256/256
(100 %)
1 diff
(99.7 %id)
BF197628 Kidney .u-u 1566 to 1783 218 to 1       218/218
(100 %)
0 diff
(100 %id)
AA435929   .u-u 1571 to 1812 242 to 1   fully sequenced,   242/242
(100 %)
0 diff
(100 %id)
BF194755 fibrotheoma, ovary .u-u 1572 to 1839 268 to 1       268/268
(100 %)
2 diff
(99.3 %id)
AA620681   .u-u 1687 to 1813 124 to 1       124/124
(100 %)
3 diff
(97.6 %id)
TI_151761799   .u-u 1832 to 2237 56 to 461   tiling clone, Submitted on the opposite strand 406/992
(40 %)
3 diff
(99.7 %id)
TI_151762862   .u-u 1832 to 2237 54 to 459     Submitted on the opposite strand 406/1015
(40 %)
5 diff
(99.6 %id)
TI_151733398   .u-u 1832 to 2237 52 to 457     Submitted on the opposite strand 406/1055
(38 %)
4 diff
(99.7 %id)
TI_151734390   .u-u 1832 to 2237 52 to 457     Submitted on the opposite strand 406/1040
(39 %)
3 diff
(99.8 %id)
BM719369 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .u-u 1840 to 2233 394 to 1   tiling clone, Submitted on the opposite strand 394/394
(100 %)
0 diff
(100 %id)
BQ188132 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .u-u 1840 to 2233 394 to 1     Submitted on the opposite strand 394/394
(100 %)
0 diff
(100 %id)
AI085277 anaplastic oligodendroglioma, brain .u-u 1860 to 2201 1 to 342     Submitted on the opposite strand 342/342
(100 %)
6 diff
(98.3 %id)
BM931322 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .u-u 1898 to 2233 337 to 1     Submitted on the opposite strand 337/337
(100 %)
6 diff
(98.3 %id)
CD248574 embryonic stem cells, WA01, passage 38 .va 1 to 779 18 to 800 W13R tiling clone,   783/933
(83 %)
16 diff
(98.3 %id)
BQ923213 epidermoid carcinoma, cell line, lung .va 183 to 743 1 to 570 R97K tiling clone,   570/1232
(46 %)
24 diff
(98.1 %id)
CK904059 Islets of Langerhans, Pancreas .va 403 to 780 1 to 378   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 378/378
(100 %)
0 diff
(100 %id)
BM021337 Islets of Langerhans, Pancreas .va 403 to 780 1 to 378   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 378/378
(100 %)
5 diff
(98.7 %id)
AI458966 carcinoid, lung .va 406 to 729 1 to 326     Submitted on the opposite strand 326/326
(100 %)
2 diff
(99.4 %id)
AW003705 Prostate .va 406 to 774 1 to 369     Submitted on the opposite strand 369/369
(100 %)
0 diff
(100 %id)
BI966196 Islets of Langerhans, Pancreas .va 419 to 780 1 to 362   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 362/362
(100 %)
0 diff
(100 %id)
AI754810 bone marrow stroma .va 429 to 780 370 to 19   AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 352/352
(100 %)
0 diff
(100 %id)
AW612053 Kidney .va 435 to 781 347 to 1   tiling clone,   347/347
(100 %)
0 diff
(100 %id)
EC533998 Prostate .va 513 to 618 1 to 106       106/106
(100 %)
0 diff
(100 %id)
F26298 pectoral muscle (after mastectomy) .va 515 to 780 18 to 282       265/282
(93 %)
6 diff
(97.9 %id)
BE221100 carcinoid, lung .va 565 to 779 215 to 1       215/215
(100 %)
0 diff
(100 %id)
AI700403 colon .va 625 to 780 156 to 1       156/156
(100 %)
0 diff
(100 %id)
AI699611 pooled germ cell tumors .va 650 to 780 131 to 1       131/131
(100 %)
0 diff
(100 %id)
D45683 lung .va 657 to 781 1 to 126     Submitted on the opposite strand 126/128
(98 %)
2 diff
(98.5 %id)
AI216847   .va 708 to 779 77 to 6       72/77
(93 %)
0 diff
(100 %id)
AF012106 placenta .vb 1 to 1341 1 to 1339 exact tiling clone, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 1339/1339
(100 %)
10 diff
(99.3 %id)
AA774966 schizophrenic brain S-11 frontal lobe .vb 502 to 942 437 to 2       436/437
(99 %)
0 diff
(100 %id)
BF996215 placenta_normal .vc-u 1 to 350 350 to 1   tiling clone,   350/350
(100 %)
2 diff
(99.5 %id)
W60375 heart .vc-u 5 to 332 1 to 342   tiling clone,   342/407
(84 %)
25 diff
(93.9 %id)
DB356794 whole embryo, mainly head .vc-u 110 to 688 1 to 580   tiling clone, Submitted on the opposite strand 580/581
(99 %)
11 diff
(98.2 %id)
N44004 multiple sclerosis lesions .vc-u 286 to 687 1 to 401   tiling clone,   401/402
(99 %)
2 diff
(99.6 %id)
BF996166 placenta_normal .vc-u 367 to 530 174 to 13       162/174
(93 %)
0 diff
(100 %id)
AI285132 adenocarcinoma, colon .vc-u 728 to 1143 422 to 7 exact tiling clone,   416/422
(98 %)
0 diff
(100 %id)
W60283 heart .vc-u 758 to 1142 384 to 1 T11Y T12N K13E P14X G15R ...     384/384
(100 %)
10 diff
(97.4 %id)
CR615814 Placenta Cot 25-normalized .vd 1 to 1071 1 to 1071   tiling clone,   1071/1071
(100 %)
0 diff
(100 %id)
BX357388 Placenta Cot 25-normalized .vd 1 to 785 1 to 784   fully sequenced,   784/784
(100 %)
4 diff
(99.5 %id)
DB536641 hippocampus .vd 692 to 1103 1 to 410 W13C L14* tiling clone, Submitted on the opposite strand 410/410
(100 %)
9 diff
(97.9 %id)
BX357387 Placenta Cot 25-normalized .vd 755 to 1071 307 to 1   fully sequenced,   307/307
(100 %)
3 diff
(99.1 %id)
BG501012 adenocarcinoma, Prostate .ve 1 to 713 1 to 710 P2R L21H L22P G23R A24S ... tiling clone,   710/738
(96 %)
22 diff
(97.1 %id)
DB549519 hippocampus .vf 1 to 449 1 to 449 exact tiling clone, Submitted on the opposite strand 449/449
(100 %)
1 diff
(99.8 %id)
DB491691 hypothalamus .vg 1 to 299 3 to 301       301/301
(100 %)
5 diff
(98.4 %id)
AF370402   .vg 1 to 2039 2 to 2040 P44R tiling clone, AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 2040/2040
(100 %)
8 diff
(99.7 %id)
DA007980   .vg 5 to 491 2 to 488   capped   487/487
(100 %)
0 diff
(100 %id)
DB466265 hippocampus .vg 32 to 390 1 to 359       359/410
(87 %)
3 diff
(99.3 %id)
DB473410 hippocampus .vg 32 to 513 1 to 482       482/482
(100 %)
1 diff
(99.8 %id)
BG421384 Kidney, renal cell adenocarcinoma .vg 35 to 692 1 to 656       656/1040
(63 %)
24 diff
(97.7 %id)
BM047788 carcinoma, cell line, Prostate .vg 56 to 688 1 to 637       637/887
(71 %)
22 diff
(97.6 %id)
TI_44459988   .vg 58 to 885 26 to 854       829/854
(97 %)
6 diff
(99.3 %id)
BI518407 leukocyte .vg 59 to 885 1 to 828   tiling clone,   828/828
(100 %)
16 diff
(98.1 %id)
CN271042 embryonic stem cells, DMSO-treated H9 cellline .vg 70 to 272 1 to 203       203/203
(100 %)
0 diff
(100 %id)
BF664255 B-cells, primary B-cells from tonsils (cell line) .vh 1 to 728 1 to 717 A26P Q28S R29G S30P R31D ... tiling clone, available from MGC,   717/889
(80 %)
15 diff
(98.4 %id)
BC010145 Primary B-Cells from Tonsils .vh 2 to 856 1 to 855 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 855/855
(100 %)
0 diff
(100 %id)
CV028457 mixed .vh 290 to 492 1 to 203       203/312
(65 %)
1 diff
(99.7 %id)
BQ183485 Knee, Osteoarthritic Cartilage .vi 1 to 697 713 to 17 exact tiling clone, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 697/697
(100 %)
0 diff
(100 %id)
AI692512 carcinoid, lung .vi 168 to 703 538 to 3 exact tiling clone,   536/538
(99 %)
0 diff
(100 %id)
AI692347 carcinoid, lung .vi 198 to 703 508 to 3 exact     506/508
(99 %)
0 diff
(100 %id)
BE218011 carcinoid, lung .vi 214 to 703 492 to 3 exact     490/492
(99 %)
0 diff
(100 %id)
AI692555 carcinoid, lung .vi 222 to 703 484 to 3 exact     482/484
(99 %)
0 diff
(100 %id)
AI700636 carcinoid, lung .vi 244 to 703 462 to 3 exact     460/462
(99 %)
0 diff
(100 %id)
BE220186 carcinoid, lung .vi 401 to 703 305 to 3 exact     303/305
(99 %)
1 diff
(99.7 %id)
AA970571 Kidney, kidney tumor .vi 405 to 671 265 to 1 A20R Q42S P43R P44H P45H ...     265/265
(100 %)
12 diff
(95.5 %id)
W32579 heart .vi 413 to 699 1 to 290 A24S R25G A26Q N27T R28E ... fully sequenced,   290/290
(100 %)
21 diff
(92.8 %id)
BX105062 heart .vi 414 to 698 1 to 285 L38X     285/287
(99 %)
1 diff
(99.7 %id)
BE784797 large cell carcinoma, lung .vi 431 to 565 1 to 133       133/133
(100 %)
2 diff
(98.5 %id)
AI620451 Prostate .vi 446 to 697 252 to 1       252/252
(100 %)
0 diff
(100 %id)
CB048867 Prostate .vi 446 to 697 10 to 261   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 252/261
(96 %)
6 diff
(97.8 %id)
AI640573 Kidney .vi 467 to 698 234 to 3       232/234
(99 %)
0 diff
(100 %id)
AW300323 Kidney .vi 467 to 698 234 to 3       232/234
(99 %)
0 diff
(100 %id)
AW003669 Prostate .vi 478 to 697 220 to 1       220/220
(100 %)
0 diff
(100 %id)
CB048866 Prostate .vi 523 to 697 214 to 40   fully sequenced, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 175/175
(100 %)
0 diff
(100 %id)
W02118 heart .vi 633 to 703 71 to 3   fully sequenced,   69/71
(97 %)
6 diff
(91.6 %id)
BG058642 blood, lymphocyte .vj 1 to 507 507 to 1 exact tiling clone,   507/509
(99 %)
2 diff
(99.7 %id)
DB542188 hippocampus .vj 33 to 508 1 to 476 exact tiling clone, Submitted on the opposite strand 476/476
(100 %)
3 diff
(99.4 %id)
EC526323 Prostate .vk 1 to 104 104 to 1 exact tiling clone,   104/104
(100 %)
0 diff
(100 %id)
68 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u-u, .va, .vb, .vc-u, .vd, .ve, .vf, .vg, .vh, .vi, .vj, .vk Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C